News Feed

Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis

PRINCETON, N.J., June 24, 2020 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced […]


Client Testimonials:

“What we like most about the was their service consistently brought Marifil Mines Ltd new viewers to our company.  The interviews are high quality, to the point, friendly and enlightening.  We have been using his […]